HIPEC Research at NYULMC

Second Look Trial

Principal Investigator: Dr. Marcovalerio Melis

Certain patients are at high risk for carcinomatosis following curative treatment for colorectal cancer. Treatment of carcinomatosis is most effective when found early, however current imaging modalities such as CT scan, PET scan and MRI are limited in their ability to detect early peritoneal recurrence. Patients enrolled in this trial undergo planned diagnostic laparoscopy 9 months after completion of their treatment for the primary tumor in order to assess for early carcinomatosis.